These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1338347)

  • 1. Neuromuscular blocking effect and placental gradient of pipecuronium bromide in elective caesarean section.
    Lee C; Kwan WF; Chen BJ; Tsai SK
    Proc Natl Sci Counc Repub China B; 1992 Jul; 16(3):119-25. PubMed ID: 1338347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neostigmine and edrophonium for reversal of pipecuronium neuromuscular blockade.
    Abdulatif M; Naguib M
    Can J Anaesth; 1991 Mar; 38(2):159-63. PubMed ID: 1850665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of different doses of pipecuronium bromide during nitrous-oxide-fentanyl anaesthesia in adult surgical patients.
    Sanfilippo M; Fierro G; Vilardi V; Rosa G; De Gregorio AL; Gasparetto A
    Eur J Anaesthesiol; 1992 Jan; 9(1):49-53. PubMed ID: 1310464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myasthenia gravis and pipecuronium--report of two cases.
    Naguib M; Sari-Kouzel A; Ashour M; Seraj M; Messahel F
    Middle East J Anaesthesiol; 1992 Feb; 11(4):381-90. PubMed ID: 1320731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intubating conditions after pipecuronium bromide: the influence of dose and time.
    Azad SS; Larijani GE; Bartkowski R; Seltzer JL; Weinberger M; Marr A; Goldberg ME
    J Clin Anesth; 1991; 3(3):202-6. PubMed ID: 1652264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response relation and time course of action of pipecuronium bromide in humans anesthetized with nitrous oxide and isoflurane, halothane, or droperidol and fentanyl.
    Wierda JM; Richardson FJ; Agoston S
    Anesth Analg; 1989 Mar; 68(3):208-13. PubMed ID: 2537588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparison between neuromuscular blocking effects of pipecuronium and vecuronium; a double blind controlled study in collaboration with 5 departments of anesthesiology].
    Suzuki H; Hashimoto Y; Hanaoka K; Amaki Y; Kobayashi T; Yamamura H
    Masui; 1994 Oct; 43(10):1583-9. PubMed ID: 7815711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the onset, spontaneous recovery and train of four fade of the clinical neuromuscular block produced by pancuronium and pipecuronium.
    Gyermek L; Cantley EM
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):600-5. PubMed ID: 7874374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between pipecuronium and suxamethonium in the dog.
    Jones RS
    Res Vet Sci; 1987 Nov; 43(3):308-12. PubMed ID: 2832912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experiences with pipecuronium bromide.
    Boros M; Szenohradszky J; Kertész A; Marosi G; Tutsek L
    Acta Chir Hung; 1983; 24(4):207-14. PubMed ID: 6322488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of pipecuronium bromide during halothane or enflurane anesthesia--a comparison with pancuronium regarding the optimal dose and the effect of volatile anesthetics on neuromuscular blockade].
    Amaki Y; Yamamura H
    Masui; 1993 Jun; 42(6):876-82. PubMed ID: 8391589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacologic effects of pipecuronium bromide (Arduan)].
    Kárpáti E; Bíró K
    Acta Pharm Hung; 1992 May; 62(3):121-6. PubMed ID: 1323913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dose-response evaluation of pipecuronium bromide in elderly patients under balanced anesthesia.
    Azad SS; Larijani GE; Goldberg ME; Beach CA; Marr AT; Seltzer JL
    J Clin Pharmacol; 1989 Jul; 29(7):657-9. PubMed ID: 2547848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response relation and time course of action of pipecuronium in patients anesthetized with nitrous oxide and sevoflurane.
    Ueda N; Masuda Y; Muteki T; Ohishi K; Tayama K; Yamashita N
    J Anesth; 1993 Apr; 7(2):151-6. PubMed ID: 15278467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Observations on the neuromuscular blocking action of pipecuronium in the dog.
    Jones RS
    Res Vet Sci; 1987 Jul; 43(1):101-3. PubMed ID: 2820005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the action of pipecuronium bromide in patients under halothane anesthesia--a comparison with pancuronium bromide regarding their neuromuscular blocking and cardiovascular effects].
    Sugai N; Yajima C; Numata K; Irimada T; Hashimoto Y; Itagaki T; Katsumata N; Suzuki H; Aoki T; Fukushima K
    Masui; 1990 Mar; 39(3):293-300. PubMed ID: 2161058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of the neuromuscular and cardiovascular effects of pipecuronium, pancuronium, atracurium, and vecuronium under isoflurane anesthesia.
    Larijani GE; Gratz I; Minassian SS; Hughes DL; Afshar M; Karayannis BN
    Pharmacotherapy; 1992; 12(4):278-82. PubMed ID: 1355599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of atracurium in caesarean section.
    Flynn PJ; Frank M; Hughes R
    Br J Anaesth; 1984 Jun; 56(6):599-605. PubMed ID: 6326787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability of pipecuronium neuromuscular blockade.
    Diefenbach C; Mellinghoff H; Buzello W
    Acta Anaesthesiol Scand; 1993 Feb; 37(2):189-91. PubMed ID: 8383402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacology of pipecuronium bromide.
    Larijani GE; Bartkowski RR; Azad SS; Seltzer JL; Weinberger MJ; Beach CA; Goldberg ME
    Anesth Analg; 1989 Jun; 68(6):734-9. PubMed ID: 2544118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.